Skip to content

Clinical trials

beta-Thalassemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Country / region: United States Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20011
20033
20043
20051
20061
20072
20085
20092
20102
20115
20122
20132
20145
20162
20173
20186
20195
20203
20215
20227
20232
20244
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting17
Active, not recruiting9
Terminated9
Unknown status4
Enrolling by invitation4
Withdrawn2
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene5
National Heart, Lung, and Blood Institute (NHLBI)4
Vertex Pharmaceuticals Incorporated4
Carelon Research3
David Williams3
Genetix Biotherapeutics Inc.3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Novartis Pharmaceuticals3
Paul Szabolcs3
Columbia University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia86
Anemia, Sickle Cell48
Thalassemia23
Hematologic Diseases14
Iron Overload12
Hemoglobinopathies11
Anemia, Diamond-Blackfan10
Genetic Diseases, Inborn10
alpha-Thalassemia6
Anemia5

Trials

Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.